Skip to main content
SpringerLink
Log in

Sitaxentan voluntarily withdrawn worldwide

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Pfizer.Pfizer Stops Clinical Trials of Thelin and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety. Media Release: 10 Dec 2010. Available from: URL: http://www.pfizer.com

  2. TGA - Therapeutic Goods Administration.Worldwide withdrawal of Thelin (sitaxentan) by Pfizer. Media Release: 10 Dec 2010. Available from: URL: http://www.tga.gov.au

  3. EMA.Thelin (sitaxentan) to be withdrawn due to cases of unpredictable serious liver injury. Media Release: 10 Dec 2010. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sitaxentan voluntarily withdrawn worldwide. React. Wkly. 1332, 2 (2010). https://doi.org/10.2165/00128415-201013320-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013320-00004

Keywords

Search

Navigation